TITLE

antisense

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p141
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the medical term "antisense" is presented. Antisense refers to the strands of genetic material having a matching but reversed order of nucleic acids. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation of the term is also provided.
ACCESSION #
21219543

 

Related Articles

  • antisense.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p153 

    A definition of the medical term "antisense" is presented, which refers to a matched but reversed order of nucleic acids in strands of genetic material.

  • Antisense Nucleic Acid.  // Encyclopedic Reference of Cancer;2001, p60 

    A definition of the term "antisense nucleic acids" is presented, which refers to nucleic acids, that is single stranded DNA or RNA of various length, that are complementary to the mRNA of a certain gene. The antisense nucleic acid sticks to the mRNA and, by mechanisms that are not completely...

  • Flexible and Frozen Sugar-Modified Nucleic Acids - Modulation of Biological Activity Through Furanose Ring Dynamics in the Antisense Strand. Mangos, Maria M.; Damha, Masad J. // Current Topics in Medicinal Chemistry;Oct2002, Vol. 2 Issue 10, p1147 

    A comparison of carbohydrate modified nucleic acids has identified key structural characteristics in antisense oligonucleotides (AON) that are necessary for sufficient clinical utility, including increased duplex stability towards RNA complements and improved hydrolytic resistance towards...

  • Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides. Delihas, Nicholas // Current Drug Targets;Jun2001, Vol. 2 Issue 2, p167 

    Antisense oligonucleotide (ASO) biotechnology has been widely used to inhibit the expression of proteins involved in human disease. ASOs are designed to bind messenger RNA transcripts via Watson-Crick base-pairing and inhibit synthesis of targeted proteins. These proteins include protein...

  • Antisense Oligonucleotides in Cancer: Recent Advances. Lebedeva, I.V.; Stein, C.A. // BioDrugs;2000, Vol. 13 Issue 3, p195 

    The activation of dominant oncogenes and inactivation of tumour suppressor genes may result in cancer. These genetic events may represent novel targets for cancer therapy. Antisense nucleic acids can be used to modulate the expression of selected genes, and to suppress malignant behaviour in...

  • Side-effects and phosphorothioates. Eckstein, Fritz // Nature Biotechnology;Jun2002, Vol. 20 Issue 6, p549 

    Examines the side effects of the antisense oligonucleotide phosphorothioates.

  • Corrigendum: Safety signal dampens reception for mipomersen antisense. Kling, Jim // Nature Biotechnology;Jul2010, Vol. 28 Issue 7, p756 

    A correction to the article "Safety Signal Dampens Reception for Mipomersen Antisense," which was published in the April 8, 2010 issue of "Nature Biotechnology" is presented.

  • Marriage of convenience. Patel, Dinshaw J. // Nature;10/7/1993, Vol. 365 Issue 6446, p490 

    Features peptide-nucleic acid (PNA) chimaeras as antisense and antigene agents. Criteria to be met; Chemical structure of PNA chimaeras; Biochemical properties; Potential for inhibition through complex formation; Mixed-sequence oligonucleotide PNAs; Distinction between homopyrimidine and...

  • Antisense Oligonucleotides and RNA Interference. Borkhardt, Arndt // Encyclopedic Reference of Molecular Pharmacology;2004, p122 

    The article presents an encyclopedia entry for the terms "antisense oligonucleotides" (ASON) and "RNA interference." It provides examples of applied ASON therapeutics. It also gives information on the non-sequence specific activities of ASON. It discusses RNA interference and explains the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics